Application 077239
- Type
- ANDA
- Sponsor
- TEVA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZALEPLON | ZALEPLON | CAPSULE;ORAL | 5MG | No | No |
| 002 | ZALEPLON | ZALEPLON | CAPSULE;ORAL | 10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077239-001 | ZALEPLON | ZALEPLON | 5MG | CAPSULE / ORAL | 2008-06-06 | ||
| A077239-002 | ZALEPLON | ZALEPLON | 10MG | CAPSULE / ORAL | 2008-06-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A077239-001 | ZALEPLON | 5MG | CAPSULE / ORAL | 2008-06-06 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A077239-002 | ZALEPLON | 10MG | CAPSULE / ORAL | 2008-06-06 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A077239-001 | ZALEPLON | 5MG | CAPSULE / ORAL | 2008-06-06 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A077239-002 | ZALEPLON | 10MG | CAPSULE / ORAL | 2008-06-06 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A077239-001 | ZALEPLON | 5MG | CAPSULE / ORAL | 2008-06-06 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A077239-002 | ZALEPLON | 10MG | CAPSULE / ORAL | 2008-06-06 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A077239-001 | ZALEPLON | 5MG | CAPSULE / ORAL | 2008-06-06 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A077239-002 | ZALEPLON | 10MG | CAPSULE / ORAL | 2008-06-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A077239-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A077239-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A077239-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A077239-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A077239-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A077239-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A077239-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A077239-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zaleplon | ZALEPLON | PD-Rx Pharmaceuticals, Inc. | a1277ef5-6072-43ff-a6ce-0a7cea58b7cb | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | Zaleplon ZALEPLON |
| zaleplon | ZALEPLON | PD-Rx Pharmaceuticals, Inc. | 2cc7adee-2c4c-4fed-9914-545e70dba773 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | zaleplon ZALEPLON |
| ZALEPLON | ZALEPLON | PD-Rx Pharmaceuticals, Inc. | 9c83b71e-8344-4c77-b7f6-a9c862f9e7dd | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | ZALEPLON ZALEPLON |
| zaleplon | ZALEPLON | Preferred Pharmaceuticals Inc. | b0476859-07af-47f1-aec7-61aea0d99d24 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | zaleplon ZALEPLON |
| Zaleplon | ZALEPLON | Preferred Pharmaceuticals Inc. | d58138d1-3378-482c-a401-958dabe1be7d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | Zaleplon ZALEPLON |
| Zaleplon | ZALEPLON | Bryant Ranch Prepack | 517953c8-22ad-41af-a869-b7e4e5b291ae | 2024-08-16 | Boxed warning, Warnings, Adverse reactions | Zaleplon ZALEPLON |
| ZALEPLON | ZALEPLON | Bryant Ranch Prepack | bec67c5d-9f8f-4490-a0b4-9b7905b565f1 | 2024-05-30 | Boxed warning, Warnings, Adverse reactions | ZALEPLON ZALEPLON |
| ZALEPLON | ZALEPLON | Rising Pharma Holdings, Inc. | cff46def-c452-49bb-abea-480de8f432bd | 2024-05-08 | Boxed warning, Warnings, Adverse reactions | ZALEPLON ZALEPLON |
| ZALEPLON | ZALEPLON | Aurobindo Pharma Limited | e092f3ca-bf44-4568-a72c-3fb2cf5b192b | 2024-05-08 | Boxed warning, Warnings, Adverse reactions | ZALEPLON ZALEPLON |
| Zaleplon | ZALEPLON | Bionpharma Inc. | 53103d2f-4453-49a8-9e36-888d919879f6 | 2024-02-13 | Boxed warning, Warnings, Adverse reactions | Zaleplon ZALEPLON |
| zaleplon | ZALEPLON | A-S Medication Solutions | 8276a418-6a4c-4b81-8170-2d3838576c6d | 2024-01-07 | Boxed warning, Warnings, Adverse reactions | zaleplon ZALEPLON |
| zaleplon | ZALEPLON | Bryant Ranch Prepack | d8c88122-ce04-4caf-bd4d-0a4368ea89ad | 2023-11-06 | Boxed warning, Warnings, Adverse reactions | zaleplon ZALEPLON |
| zaleplon | ZALEPLON | Bryant Ranch Prepack | b8032b14-5068-19d5-e063-839ed25d7200 | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | zaleplon ZALEPLON |
| zaleplon | ZALEPLON | Unichem Pharmaceuticals (USA), Inc. | 57a1a11d-7767-4caf-b98a-75d7561d9165 | 2021-06-28 | Boxed warning, Warnings, Adverse reactions | zaleplon ZALEPLON |
| Zaleplon | ZALEPLON | Hikma Pharmaceuticals USA Inc. | cadd9d75-2139-4fab-94ce-2992e6a55780 | 2019-08-26 | Boxed warning, Warnings, Adverse reactions | Zaleplon ZALEPLON |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-5268 | Zaleplon | Zaleplon | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5268 | Zaleplon | Zaleplon | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5269 | Zaleplon | Zaleplon | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5269 | Zaleplon | Zaleplon | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 50090-3420 | Zaleplon | Zaleplon | A-S Medication Solutions | ANDA | Current |
| 50436-1006 | Zaleplon | Zaleplon | Unit Dose Services | ANDA | Current |
| 55700-190 | Zaleplon | Zaleplon | Lake Erie Medical DBA Quality Care Products LLC | ANDA | Current |
| 66336-056 | Zaleplon | Zaleplon | Dispensing Solutions, Inc. | ANDA | Current |